Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

Introduction Heart transplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases. Results We identified 27 children (66.7% On a median follow-up of 35.07 months (IQR: 13.13–111.87),

Heart Transplant 59

Heart Transplant Transplant Arrhythmia Pacemaker 59

Circulation: Genomic and Precision Medicine

SEPTEMBER 28, 2023

When treatable causes are excluded, studies to define causes are often abandoned, resulting in a diagnosis of end-stage idiopathic cardiomyopathy. The frequency of pathogenic variants was similar in pediatric (42.9%) and adult (43.6%) samples, but the distribution of mutated genes differed (P=8.30×10-4).

Heart Transplant 40

Heart Transplant Transplant Cardiomyopathy Pediatrics 40

Circulation

NOVEMBER 11, 2024

Background:Despite the role of cardiac catheterization for hemodynamic assessment and endomyocardial biopsy (EMB) in children with cardiomyopathy, data on procedure-related major adverse events (MAE) in this population is lacking. We aim to describe the rate of MAE in children with cardiomyopathy undergoing cardiac catheterization.

Cardiomyopathy 40

Cardiomyopathy Pediatrics Heart Transplant Heart Failure 40

Stroke Journal

JANUARY 30, 2025

Introduction:Pediatric heart transplant (PHT) recipient survival has improved. Yet, neurologic morbidity related to heart failure and its treatment persist. CHD was the pre-PHT diagnosis in 21(62%) of stroke Pts, cardiomyopathy in 12(35%) and acquired heart disease in 1(3%).

Heart Transplant 40

Heart Transplant Transplant Pediatrics Stroke 40

Circulation

JANUARY 9, 2025

BACKGROUND:The United Network of Organ Sharing made changes to the priority for allocation of hearts for transplantation (HT) in 2016 for pediatric patients and 2018 for adult patients. Circulation, Ahead of Print.

Congenital Heart Disease 49

Congenital Heart Disease Pediatrics Cardiomyopathy Transplant 49

Journal of the American Heart Association

JANUARY 12, 2024

Journal of the American Heart Association, Ahead of Print. BackgroundPediatric dilated cardiomyopathy often leads to death or cardiac transplantation. The risk for death or cardiac transplantation up to 7 years later was lower when LVFS was improved at 1 year (hazard ratio [HR], 0.83;P=0.004) P<0.001).ConclusionsProgressive

Cardiomyopathy 40

Cardiomyopathy Pediatrics Transplant Heart Transplant 40

Cardiometabolic Health Congress

MARCH 8, 2024

However, women remain concentrated in certain specialties (pediatrics and women’s specialties) and are less likely to be promoted to healthcare leadership roles. Dr. Lala-Trindade serves as the director of Heart Failure Research and leads the Data Coordinating Center for the NHLBI Cardiothoracic Surgery Network.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59